{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:44:07Z","timestamp":1788914647423,"version":"build-2803163510"},"reference-count":92,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T00:00:00Z","timestamp":1696982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Metabolic (dysfunction) associated fatty liver disease (MAFLD) is generally developed with excessive accumulation of lipids in the liver. Ketogenesis is an efficient pathway for the disposal of fatty acids in the liver and its metabolic benefits have been reported. In this review, we examined previous studies on the association between ketogenesis and MAFLD and reviewed the candidate mechanisms that can explain this association.<\/jats:p>","DOI":"10.3390\/biom13101506","type":"journal-article","created":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T08:07:12Z","timestamp":1697011632000},"page":"1506","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Association between Impaired Ketogenesis and Metabolic-Associated Fatty Liver Disease"],"prefix":"10.3390","volume":"13","author":[{"given":"Jaehyun","family":"Bae","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, Catholic Kwandong University College of Medicine, International St. Mary\u2019s Hospital, Incheon 22711, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9899-4992","authenticated-orcid":false,"given":"Byung-Wan","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, Yonsei University College of Medicine, Seoul 03722, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,10,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.bi.49.070180.002143","article-title":"Regulation of hepatic fatty acid oxidation and ketone body production","volume":"49","author":"McGarry","year":"1980","journal-title":"Annu. Rev. Biochem."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0140-6736(04)16986-9","article-title":"Atkins and other low-carbohydrate diets: Hoax or an effective tool for weight loss?","volume":"364","author":"Astrup","year":"2004","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1111\/dom.13488","article-title":"Increases in circulating levels of ketone bodies and cardiovascular protection with sglt2 inhibitors: Is low-grade inflammation the neglected component?","volume":"20","author":"Prattichizzo","year":"2018","journal-title":"Diabetes Obes. Metab."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.2337\/dc16-0330","article-title":"Cv protection in the empa-reg outcome trial: A \u201cthrifty substrate\u201d hypothesis","volume":"39","author":"Ferrannini","year":"2016","journal-title":"Diabetes Care"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2017.04.011","article-title":"Sodium-glucose co-transporters and their inhibition: Clinical physiology","volume":"26","author":"Ferrannini","year":"2017","journal-title":"Cell Metab."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.3346\/jkms.2010.25.12.1771","article-title":"Ketonuria after fasting may be related to the metabolic superiority","volume":"25","author":"Joo","year":"2010","journal-title":"J. Korean Med. Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s00125-019-4829-x","article-title":"Spontaneous ketonuria and risk of incident diabetes: A 12 year prospective study","volume":"62","author":"Kim","year":"2019","journal-title":"Diabetologia"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1124576","DOI":"10.3389\/fendo.2023.1124576","article-title":"Impaired ketogenesis is associated with metabolic-associated fatty liver disease in subjects with type 2 diabetes","volume":"14","author":"Lee","year":"2023","journal-title":"Front. Endocrinol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMra1503519","article-title":"Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis","volume":"377","author":"Diehl","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the american association for the study of liver diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (nafld) and nonalcoholic steatohepatitis (nash): A systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"Mafld: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"De, A., Bhagat, N., Mehta, M., Taneja, S., and Duseja, A. (J. Hepatol., 2023). Metabolic dysfunction-associated steatotic liver disease (masld) definition is better than mafld criteria for lean patients with non-alcoholic fatty liver disease (nafld), J. Hepatol., in press.","DOI":"10.1016\/j.jhep.2023.07.031"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"Nafld: A multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.3350\/cmh.2022.0424","article-title":"Non-alcoholic fatty liver disease: Definition and subtypes","volume":"29","author":"Han","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Ter Horst, K.W., and Serlie, M.J. (2017). Fructose consumption, lipogenesis, and non-alcoholic fatty liver disease. Nutrients, 9.","DOI":"10.3390\/nu9090981"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.gastro.2013.11.049","article-title":"Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease","volume":"146","author":"Lambert","year":"2014","journal-title":"Gastroenterology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J. Clin. Investig."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of nafld development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1053\/j.gastro.2007.03.059","article-title":"Obesity, inflammation, and insulin resistance","volume":"132","author":"Shoelson","year":"2007","journal-title":"Gastroenterology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/j.1464-5491.2012.03732.x","article-title":"Dorothy hodgkin lecture 2012: Non-alcoholic fatty liver disease, insulin resistance and ectopic fat: A new problem in diabetes management","volume":"29","author":"Byrne","year":"2012","journal-title":"Diabet. Med. A J. Br. Diabet. Assoc."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3350\/cmh.2013.19.3.210","article-title":"Nonalcoholic fatty liver disease: Molecular mechanisms for the hepatic steatosis","volume":"19","author":"Koo","year":"2013","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.metabol.2010.10.003","article-title":"Lipid in the livers of adolescents with nonalcoholic steatohepatitis: Combined effects of pathways on steatosis","volume":"60","author":"Zhu","year":"2011","journal-title":"Metab. Clin. Exp."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.2337\/db07-0156","article-title":"Genes involved in fatty acid partitioning and binding, lipolysis, monocyte\/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects","volume":"56","author":"Westerbacka","year":"2007","journal-title":"Diabetes"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"G1281","DOI":"10.1152\/ajpgi.00074.2008","article-title":"Gene expression in human nafld","volume":"294","author":"Greco","year":"2008","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1136\/gut.2010.222844","article-title":"Hepatic fatty acid translocase cd36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis c","volume":"60","author":"Ochoa","year":"2011","journal-title":"Gut"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/brv.12178","article-title":"De novo lipogenesis in the liver in health and disease: More than just a shunting yard for glucose","volume":"91","author":"Sanders","year":"2016","journal-title":"Biol. Rev. Camb. Philos. Soc."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Geidl-Flueck, B., and Gerber, P.A. (2017). Insights into the hexose liver metabolism-glucose versus fructose. Nutrients, 9.","DOI":"10.3390\/nu9091026"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease","volume":"75","author":"Ipsen","year":"2018","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.biochi.2004.09.018","article-title":"Srebp transcription factors: Master regulators of lipid homeostasis","volume":"86","author":"Hegarty","year":"2004","journal-title":"Biochimie"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"9116","DOI":"10.1073\/pnas.161284298","article-title":"A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver","volume":"98","author":"Yamashita","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.bbalip.2011.09.017","article-title":"Fatty acid synthase and liver triglyceride metabolism: Housekeeper or messenger?","volume":"1821","author":"Semenkovich","year":"2012","journal-title":"Biochim. Et Biophys. Acta"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"101238","DOI":"10.1016\/j.molmet.2021.101238","article-title":"Metabolic-associated fatty liver disease and lipoprotein metabolism","volume":"50","author":"Heeren","year":"2021","journal-title":"Mol. Metab."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1053\/j.gastro.2007.11.038","article-title":"Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease","volume":"134","author":"Fabbrini","year":"2008","journal-title":"Gastroenterology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1172\/JCI6246","article-title":"Disruption of ldl receptor gene in transgenic srebp-1a mice unmasks hyperlipidemia resulting from production of lipid-rich vldl","volume":"103","author":"Horton","year":"1999","journal-title":"J. Clin. Investig."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/(SICI)1520-7560(199911\/12)15:6<412::AID-DMRR72>3.0.CO;2-8","article-title":"Ketone bodies: A review of physiology, pathophysiology and application of monitoring to diabetes","volume":"15","author":"Laffel","year":"1999","journal-title":"Diabetes\/Metab. Res. Rev."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"946474","DOI":"10.3389\/fphys.2022.946474","article-title":"Emerging role of hepatic ketogenesis in fatty liver disease","volume":"13","author":"Mooli","year":"2022","journal-title":"Front. Physiol."},{"key":"ref_38","first-page":"193","article-title":"Medical aspects of ketone body metabolism","volume":"18","author":"Mitchell","year":"1995","journal-title":"Clin. Investig. Med. Med. Clin. Et Exp."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Abdul Kadir, A., Clarke, K., and Evans, R.D. (2020). Cardiac ketone body metabolism. Biochim. Et Biophys. Acta. Mol. Basis Dis., 1866.","DOI":"10.1016\/j.bbadis.2020.165739"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"H1060","DOI":"10.1152\/ajpheart.00646.2012","article-title":"Ketone body metabolism and cardiovascular disease","volume":"304","author":"Cotter","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"E1226","DOI":"10.1152\/ajpendo.00033.2010","article-title":"Progressive adaptation of hepatic ketogenesis in mice fed a high-fat diet","volume":"298","author":"Sunny","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"110910","DOI":"10.1016\/j.celrep.2022.110910","article-title":"Atgl-dependent white adipose tissue lipolysis controls hepatocyte ppar\u03b1 activity","volume":"39","author":"Fougerat","year":"2022","journal-title":"Cell Rep."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1113\/jphysiol.1980.sp013190","article-title":"Post-exercise ketosis","volume":"301","author":"Koeslag","year":"1980","journal-title":"J. Physiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1113\/JP273185","article-title":"Metabolism of ketone bodies during exercise and training: Physiological basis for exogenous supplementation","volume":"595","author":"Evans","year":"2017","journal-title":"J. Physiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/dmr.5610050306","article-title":"Human ketone body production and utilization studied using tracer techniques: Regulation by free fatty acids, insulin, catecholamines, and thyroid hormones","volume":"5","author":"Keller","year":"1989","journal-title":"Diabetes\/Metab. Rev."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1172\/JCI107537","article-title":"Effects of glucagon on lipolysis and ketogenesis in normal and diabetic men","volume":"53","author":"Liljenquist","year":"1974","journal-title":"J. Clin. Investig."},{"key":"ref_47","first-page":"163","article-title":"Hormonal regulation of ketone-body metabolism in man","volume":"43","author":"Alberti","year":"1978","journal-title":"Biochem. Soc. Symp."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1128\/MCB.01584-12","article-title":"Insulin inhibits lipolysis in adipocytes via the evolutionarily conserved mtorc1-egr1-atgl-mediated pathway","volume":"33","author":"Chakrabarti","year":"2013","journal-title":"Mol. Cell. Biol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/dmr.5610050305","article-title":"Regulation of ketogenesis and the renaissance of carnitine palmitoyltransferase","volume":"5","author":"McGarry","year":"1989","journal-title":"Diabetes\/Metab. Rev."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"978","DOI":"10.2169\/internalmedicine.31.978","article-title":"Resistance to ketosis in moderately obese patients: Influence of fatty liver","volume":"31","author":"Inokuchi","year":"1992","journal-title":"Intern. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1136\/gutjnl-2012-302789","article-title":"Whole-body substrate metabolism is associated with disease severity in patients with non-alcoholic fatty liver disease","volume":"62","author":"Croci","year":"2013","journal-title":"Gut"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"E187","DOI":"10.1152\/ajpendo.00058.2020","article-title":"\u0392-hydroxybutyrate is reduced in humans with obesity-related nafld and displays a dose-dependent effect on skeletal muscle mitochondrial respiration in vitro","volume":"319","author":"Mey","year":"2020","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e127737","DOI":"10.1172\/jci.insight.127737","article-title":"Impaired ketogenesis and increased acetyl-coa oxidation promote hyperglycemia in human fatty liver","volume":"5","author":"Fletcher","year":"2019","journal-title":"JCI Insight"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jhep.2011.06.010","article-title":"Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review","volume":"56","author":"Thoma","year":"2012","journal-title":"J. Hepatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1053\/j.gastro.2009.01.048","article-title":"Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction","volume":"136","author":"Kirk","year":"2009","journal-title":"Gastroenterology"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"7347","DOI":"10.1073\/pnas.1922344117","article-title":"Effect of a ketogenic diet on hepatic steatosis and hepatic mitochondrial metabolism in nonalcoholic fatty liver disease","volume":"117","author":"Luukkonen","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1053\/gast.2001.23256","article-title":"Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities","volume":"120","author":"Sanyal","year":"2001","journal-title":"Gastroenterology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s00125-005-1682-x","article-title":"Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: Sites and mechanisms","volume":"48","author":"Bugianesi","year":"2005","journal-title":"Diabetologia"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2003.50095","article-title":"Hepatic cytochrome p450 2e1 activity in nondiabetic patients with nonalcoholic steatohepatitis","volume":"37","author":"Chalasani","year":"2003","journal-title":"Hepatology"},{"key":"ref_60","first-page":"1439","article-title":"Liver fat and lipid oxidation in humans","volume":"29","author":"Kotronen","year":"2009","journal-title":"Liver Int. Off. J. Int. Assoc. Study Liver"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e13627","DOI":"10.1111\/eci.13627","article-title":"Nonalcoholic fatty liver disease, circulating ketone bodies and all-cause mortality in a general population-based cohort","volume":"51","author":"Post","year":"2021","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.14309\/ajg.0000000000001344","article-title":"Fasting ketonuria and the risk of incident nonalcoholic fatty liver disease with and without liver fibrosis in nondiabetic adults","volume":"116","author":"Kim","year":"2021","journal-title":"Am. J. Gastroenterol."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Lim, K., Kang, M., and Park, J. (2021). Association between fasting ketonuria and advanced liver fibrosis in non-alcoholic fatty liver disease patients without prediabetes and diabetes mellitus. Nutrients, 13.","DOI":"10.3390\/nu13103400"},{"key":"ref_64","first-page":"1853","article-title":"Ketone body production is differentially altered in steatosis and non-alcoholic steatohepatitis in obese humans","volume":"35","author":"Simonen","year":"2015","journal-title":"Liver Int. Off. J. Int. Assoc. Study Liver"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0026-0495(72)90059-5","article-title":"Regulation of ketogenesis and clinical aspects of the ketotic state","volume":"21","author":"McGarry","year":"1972","journal-title":"Metab. Clin. Exp."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0026-0495(79)90166-5","article-title":"Kinetics of ketone body metabolism in fasting humans","volume":"28","author":"Balasse","year":"1979","journal-title":"Metab. Clin. Exp."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"5175","DOI":"10.1172\/JCI76388","article-title":"Ketogenesis prevents diet-induced fatty liver injury and hyperglycemia","volume":"124","author":"Cotter","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"e99762","DOI":"10.1172\/jci.insight.99762","article-title":"Hepatic ketogenic insufficiency reprograms hepatic glycogen metabolism and the lipidome","volume":"3","author":"Puchalska","year":"2018","journal-title":"JCI Insight"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Arroyave-Ospina, J.C., Wu, Z., Geng, Y., and Moshage, H. (2021). Role of oxidative stress in the pathogenesis of non-alcoholic fatty liver disease: Implications for prevention and therapy. Antioxidants, 10.","DOI":"10.3390\/antiox10020174"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.cmet.2007.05.002","article-title":"Hepatic fibroblast growth factor 21 is regulated by pparalpha and is a key mediator of hepatic lipid metabolism in ketotic states","volume":"5","author":"Badman","year":"2007","journal-title":"Cell Metab."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/dom.13577","article-title":"Sodium-glucose cotransporter 2 inhibitors regulate ketone body metabolism via inter-organ crosstalk","volume":"21","author":"Kim","year":"2019","journal-title":"Diabetes Obes. Metab."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s12020-019-02124-3","article-title":"Liver-derived fgf21 is essential for full adaptation to ketogenic diet but does not regulate glucose homeostasis","volume":"67","author":"Watanabe","year":"2020","journal-title":"Endocrine"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3389\/fendo.2014.00107","article-title":"Fgf21 as a hepatokine, adipokine, and myokine in metabolism and diseases","volume":"5","author":"Itoh","year":"2014","journal-title":"Front. Endocrinol."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Itoh, N., Nakayama, Y., and Konishi, M. (2016). Roles of fgfs as paracrine or endocrine signals in liver development, health, and disease. Front. Cell Dev. Biol., 4.","DOI":"10.3389\/fcell.2016.00030"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00535-017-1415-1","article-title":"Current and future pharmacological therapies for nafld\/nash","volume":"53","author":"Sumida","year":"2018","journal-title":"J. Gastroenterol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"4084","DOI":"10.1210\/en.2009-0221","article-title":"Fibroblast growth factor 21 controls glycemia via regulation of hepatic glucose flux and insulin sensitivity","volume":"150","author":"Berglund","year":"2009","journal-title":"Endocrinology"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cmet.2013.08.005","article-title":"The effects of ly2405319, an fgf21 analog, in obese human subjects with type 2 diabetes","volume":"18","author":"Gaich","year":"2013","journal-title":"Cell Metab."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.tem.2013.09.002","article-title":"Ketone bodies as signaling metabolites","volume":"25","author":"Newman","year":"2014","journal-title":"Trends Endocrinol. Metab. TEM"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"26649","DOI":"10.1074\/jbc.C500213200","article-title":"(d)-beta-hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor puma-g","volume":"280","author":"Taggart","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41392-023-01415-6","article-title":"3-hydroxybutyrate ameliorates insulin resistance by inhibiting ppar\u03b3 ser273 phosphorylation in type 2 diabetic mice","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/0026-0495(76)90066-4","article-title":"Blood d-3-hydroxybutyrate and the regulation of plasma concentrations of free fatty acids in the fasted rat","volume":"25","author":"Bates","year":"1976","journal-title":"Metab. Clin. Exp."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/219083a0","article-title":"Direct regulatory effect of ketones on lipolysis and on glucose concentrations in man","volume":"219","author":"Senior","year":"1968","journal-title":"Nature"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S0140-6736(03)13105-4","article-title":"D,l-3-hydroxybutyrate treatment of multiple acyl-coa dehydrogenase deficiency (madd)","volume":"361","author":"Jaeken","year":"2003","journal-title":"Lancet"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"e00264","DOI":"10.1002\/edm2.264","article-title":"Exogenous ketosis in patients with type 2 diabetes: Safety, tolerability and effect on glycaemic control","volume":"4","author":"Norwitz","year":"2021","journal-title":"Endocrinol. Diabetes Metab."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"777","DOI":"10.14336\/AD.2019.0926","article-title":"\u0392-hydroxybutyrate suppresses lipid accumulation in aged liver through gpr109a-mediated signaling","volume":"11","author":"Lee","year":"2020","journal-title":"Aging Dis."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"8030","DOI":"10.1073\/pnas.1016088108","article-title":"Short-chain fatty acids and ketones directly regulate sympathetic nervous system via g protein-coupled receptor 41 (gpr41)","volume":"108","author":"Kimura","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41420-022-00840-w","article-title":"Bdh1 overexpression ameliorates hepatic injury by activation of nrf2 in a mafld mouse model","volume":"8","author":"Xu","year":"2022","journal-title":"Cell Death Discov."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nm.3804","article-title":"The ketone metabolite \u03b2-hydroxybutyrate blocks nlrp3 inflammasome-mediated inflammatory disease","volume":"21","author":"Youm","year":"2015","journal-title":"Nat. Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"66444","DOI":"10.18632\/oncotarget.12119","article-title":"\u0392-hydroxybutyrate suppresses inflammasome formation by ameliorating endoplasmic reticulum stress via ampk activation","volume":"7","author":"Bae","year":"2016","journal-title":"Oncotarget"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Carnagarin, R., Tan, K., Adams, L., Matthews, V.B., Kiuchi, M.G., Marisol Lugo Gavidia, L., Lambert, G.W., Lambert, E.A., Herat, L.Y., and Schlaich, M.P. (2021). Metabolic dysfunction-associated fatty liver disease (mafld)-a condition associated with heightened sympathetic activation. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22084241"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"781567","DOI":"10.3389\/fmed.2021.781567","article-title":"Inflammation and fibrogenesis in mafld: Role of the hepatic immune system","volume":"8","author":"Torre","year":"2021","journal-title":"Front. Med."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Li, K., Wang, W.H., Wu, J.B., and Xiao, W.H. (2023). \u0392-hydroxybutyrate: A crucial therapeutic target for diverse liver diseases. Biomed. Pharmacother. = Biomed. Pharmacother., 165.","DOI":"10.1016\/j.biopha.2023.115191"}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/13\/10\/1506\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:04:57Z","timestamp":1760130297000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/13\/10\/1506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,11]]},"references-count":92,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["biom13101506"],"URL":"https:\/\/doi.org\/10.3390\/biom13101506","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,11]]}}}